NOVEL COMPOUNDS SYNERGIZE WITH VENETOCLAX TO TARGET KMT2A-REARRANGED ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Tregnago, C. [1 ]
Benetton, M. [1 ]
Da Ros, A. [1 ]
Borella, G. [1 ]
Longo, G. [1 ]
Polato, K. [1 ]
Francescato, S. [1 ]
Biffi, A. [1 ]
Pigazzi, M. [1 ]
机构：
[1] Univ Padua, Dipartimento Salute Donna & Bambino, Div Ematooncol Pediat & Terapia Cellulare & Gen, Padua, Italy
来源：
HAEMATOLOGICA | 2022年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P23
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [11] Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML)
    Ball, Brian J.
    Arslan, Shukaib
    Koller, Paul
    Ngo, Dat
    Afkhami, Michelle
    Salhotra, Amandeep
    Al-Malki, Monzr
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Otoukesh, Salman
    Amanam, Idoroenyi
    Pourhassan, Hoda
    Artz, Andrew
    Curtin, Peter
    Stein, Anthony
    Nakamura, Ryotaro
    Marcucci, Guido
    Smith, Eileen
    Pullarkat, Vinod
    Aldoss, Ibrahim
    LEUKEMIA & LYMPHOMA, 2022, 63 (13) : 3232 - 3236
  • [12] Clonal Evolution Pattern and Prognostic Significance of Clonal Architecture in KMT2A-Rearranged Acute Myeloid Leukemia
    Matsuo, Hidemasa
    Yoshida, Kenichi
    Nannya, Yasuhito
    Ito, Yuri
    Saito, Shoji
    Koga, Yuhki
    Moritake, Hiroshi
    Terui, Kiminori
    Kawaguchi, Koji
    Okamoto, Yasuhiro
    Nakayama, Hideki
    Miyako, Kanno
    Hino, Moeko
    Akane, Yusuke
    Inoue, Akiko
    Shimada, Akira
    Goto, Hiroaki
    Ueno, Hiroo
    Takita, Junko
    Yamato, Genki
    Shiba, Norio
    Hayashi, Yasuhide
    Shiraishi, Yuichi
    Miyano, Satoru
    Kiyokawa, Nobutaka
    Tomizawa, Daisuke
    Taga, Takashi
    Tawa, Akio
    Ogawa, Seishi
    Adachi, Souichi
    BLOOD, 2021, 138
  • [13] Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy
    Cheung, Laurence C.
    Aya-Bonilla, Carlos
    Cruickshank, Mark N.
    Chiu, Sung K.
    Kuek, Vincent
    Anderson, Denise
    Chua, Grace-Alyssa
    Singh, Sajla
    Oommen, Joyce
    Ferrari, Emanuela
    Hughes, Anastasia M.
    Ford, Jette
    Kunold, Elena
    Hesselman, Maria C.
    Post, Frederik
    Faulk, Kelly E.
    Breese, Erin H.
    Guest, Erin M.
    Brown, Patrick A.
    Loh, Mignon L.
    Lock, Richard B.
    Kees, Ursula R.
    Jafari, Rozbeh
    Malinge, Sebastien
    Kotecha, Rishi S.
    LEUKEMIA, 2023, 37 (01) : 61 - 71
  • [14] Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy
    Laurence C. Cheung
    Carlos Aya-Bonilla
    Mark N. Cruickshank
    Sung K. Chiu
    Vincent Kuek
    Denise Anderson
    Grace-Alyssa Chua
    Sajla Singh
    Joyce Oommen
    Emanuela Ferrari
    Anastasia M. Hughes
    Jette Ford
    Elena Kunold
    Maria C. Hesselman
    Frederik Post
    Kelly E. Faulk
    Erin H. Breese
    Erin M. Guest
    Patrick A. Brown
    Mignon L. Loh
    Richard B. Lock
    Ursula R. Kees
    Rozbeh Jafari
    Sébastien Malinge
    Rishi S. Kotecha
    Leukemia, 2023, 37 : 61 - 71
  • [15] Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia
    Cheung, Laurence C.
    de Kraa, Rebecca
    Oommen, Joyce
    Chua, Grace-Alyssa
    Singh, Sajla
    Hughes, Anastasia M.
    Ferrari, Emanuela
    Ford, Jette
    Chiu, Sung K.
    Stam, Ronald W.
    Kees, Ursula R.
    Malinge, Sebastien
    Kotecha, Rishi S.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [16] Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias
    Lopes, Bruno A.
    Poubel, Caroline Pires
    Teixeira, Cristiane Esteves
    Caye-Eude, Aurelie
    Cave, Helene
    Meyer, Claus
    Marschalek, Rolf
    Boroni, Mariana
    Emerenciano, Mariana
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [17] Recent Developments and Evolving Therapeutic Strategies in KMT2A-Rearranged Acute Leukemia
    Yin, Lei
    Wan, Lin
    Zhang, Youjian
    Hua, Shenghao
    Shao, Xuejun
    CANCER MEDICINE, 2024, 13 (20):
  • [18] Preclinical Assessment of Dactinomycin in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia
    Chiu, Sung K.
    Ferrari, Emanuela
    Oommen, Joyce
    Malinge, Sebastien
    Cheung, Laurence C.
    Kotecha, Rishi S.
    CANCERS, 2025, 17 (03)
  • [19] Decoding the Epigenetic Drivers of Menin-MLL Inhibitor Resistance in KMT2A-Rearranged Acute Myeloid Leukemia
    Zhou, Xinyue
    Zhang, Lixia
    Aryal, Sajesan
    Moreira, Steven
    Veasey, Virginia
    Hope, Kristin J.
    Lu, Rui
    BLOOD, 2023, 142
  • [20] KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia
    Iyoda, Shinju
    Yoshida, Kenichi
    Shoji, Kota
    Ito, Nana
    Tanaka, Miu
    Nannya, Yasuhito
    Yamato, Genki
    Tsujimoto, Shinichi
    Shiba, Norio
    Hayashi, Yasuhide
    Shiozawa, Yusuke
    Shiraishi, Yuichi
    Chiba, Kenichi
    Okada, Ai
    Tanaka, Hiroko
    Miyano, Satoru
    Koga, Yuhki
    Goto, Hiroaki
    Moritake, Hiroshi
    Terui, Kiminori
    Ito, Etsuro
    Kiyokawa, Nobutaka
    Tomizawa, Daisuke
    Taga, Takashi
    Tawa, Akio
    Takita, Junko
    Nishikori, Momoko
    Adachi, Souichi
    Ogawa, Seishi
    Matsuo, Hidemasa
    LEUKEMIA, 2024, 38 (07) : 1609 - 1612
12345